Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Sep-Oct;31(5):e566-e572.
doi: 10.1097/MJT.0000000000001715. Epub 2024 Aug 9.

Efficacy and Safety of Bempedoic Acid for Prevention of Adverse Cardiovascular Events and Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Farah Yasmin  1 , Hala Najeeb  2 , Abdul Moeed  2 , Eman Ali  2 , Muhammad Umar  3 , Irfan Ullah  4 , Nishant Shah  5 , M Chadi Alraies  6
Affiliations
Meta-Analysis

Efficacy and Safety of Bempedoic Acid for Prevention of Adverse Cardiovascular Events and Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Farah Yasmin et al. Am J Ther. 2024 Sep-Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

References

    1. Jeong SM, Choi S, Kim K, et al. Effect of change in total cholesterol levels on cardiovascular disease among young adults. J Am Heart Assoc. 2018;7:e008819.
    1. Toth PP, Bray S, Villa G, et al. Network meta‐analysis of randomized trials evaluating the comparative efficacy of lipid‐lowering therapies added to maximally tolerated statins for the reduction of low‐density lipoprotein cholesterol. J Am Heart Assoc. 2022;11:e025551.
    1. Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38:2459–2472.
    1. Serban MC, Colantonio LD, Manthripragada AD, et al. Statin intolerance and risk of coronary Heart events and all-cause mortality following myocardial infarction. J Am Coll Cardiol. 2017;69:1386–1395.
    1. New Lipid-Lowering Drug Earns FDA Approval [Internet]. Available at: https://www.medscape.com/viewarticle/925580 . Accessed April 27, 2023.

MeSH terms

Substances

LinkOut - more resources